(Press-News.org) Vienna, Austria: Injuries occurring to people who ride e-scooters cost Irish hospitals an average of €1,726 per patient, and researchers have calculated the total overall cost to one hospital in a single year was €128,650.
Dr Thomas Suttie, a senior house officer in emergency medicine at Connolly Hospital Blanchardstown, Abbotstown, Dublin, Ireland, told the European Emergency Medicine Congress today (Monday): “In 2021 we published the number of patients who came to the emergency department of our suburban hospital as a result of e-scooter injuries, and recently we published an update that showed these figures had more than tripled in 2023. Today I am presenting the results of the follow-on project to delineate the financial costs of them. We believe this is the first study that quantifies these costs in Ireland.” [1]
Dr Suttie and colleagues gathered data on the cost of emergency department attendances, admissions to acute care wards in their hospital, radiologic investigations, surgery and outpatient attendances for the 76 patients who presented at the hospital with injuries from e-scooter accidents in 2023.
E-scooter injuries were mainly musculoskeletal, often involving complex trauma that required major surgery.
“These often placed a burden on our orthopaedic colleagues, as these patients required orthopaedic follow-up with or without surgery or hospital admission. Thirteen patients required orthopaedic admission and 34 patients, including those who were admitted, required outpatient follow-up,” said Dr Suttie. “The other type of injury was usually head injuries, which did not require medical intervention. There were no deaths among the patients with head injuries, nor were they admitted to the intensive care unit.”
The researchers found that their suburban hospital spent €128,650 in 2023 on treating e-scooter injuries. In addition to the average cost per patient of €1,726, the total cost of emergency department attendances was €35,264; the total cost of following up these patients as outpatients was €17,380; and the total cost of hospital admission was €75,600.
“The costs were staggering,” said Dr Suttie. “We knew there was a novel burden on our emergency department and orthopaedic team from e-scooter injuries, but it was interesting to discover how much they cost.”
The researchers believe their findings can be extrapolated to other hospitals in Ireland and the costs could be even higher for some.
“As our hospital is a suburban one, it is not where the majority of e-scooter riding and injuries occur in Dublin. Dublin’s city centre hospitals would see more and the cost of them is likely to be significantly higher than in our hospital.
“E-scooter injuries are associated with significant costs and place an additional challenge on an already stretched health care system. Further funding needs to be made available to treat them and alleviate the burden that has been placed on health care services.
“Changes to legislation and public health measures, such as making helmets compulsory or ensuring e-scooters comply with new and existing legislation and that these points continue to be enforced, could make a big impact on the number of injuries, the cost to users and to the health service,” concluded Dr Suttie.
A second abstract presented at the congress as a poster [2] looked at the outcomes in Dublin of recent changes in the law for e-scooters in Ireland. From May 2024, e-scooters could be ridden on roads but the riders have to be over 16 and adhere to the 20 km an hour speed limit. The study found that injuries to those aged under 16 decreased, but the overall injury rate increased, helmet use dropped, and the involvement of alcohol or substance abuse increased among injured patients. Admissions to hospital also increased.
Dr Felix Lorang is a member of the EUSEM abstract selection committee. He is head of the emergency department at SRH Zentralklinikum Suhl, Thuringia, Germany, and was not involved with the research. He said: “E-scooter use has risen exponentially in recent years in several European countries, including Ireland. The study by Dr Suttie and colleagues reveals the large increased cost to one hospital of admitting and treating patients with injuries caused by riding e-scooters. Though only looking at costs, these data show that hospitals all over Europe will face a rising burden of patients with e-scooter-related injuries. This suggests that we need to take steps not only to make e-scooter use safer, but also to prepare for different kinds of injuries to those we are used to seeing.”
(ends)
[1] Abstract no: OA152, “Retrospective review and cost-based analysis of electric scooter (e-scooter) injuries presenting to an Irish Hospital” by Thomas Suttie, oral abstract session on trauma, Monday 29 September, 11:00-12:30 hrs CEST, Schubert 5 room: https://eusem.floq.live/kiosk/eusem-2025/dailyprogramme?objectClass=timeslot&objectId=68871e9e626af251d24be29f&type=detail
[2] Abstract no: POS409, “Electric scooter-related maxillofacial injuries: outcome of recent legislation change in Ireland”, by Min Seo Jung, ‘Clinical policy, legislation & well-being’ poster display session, Monday 29 September, 09:40-09:45 hrs CEST, Exhibition Hall, screen #4: https://eusem.floq.live/kiosk/eusem-2025/dailyprogramme?objectClass=timeslot&objectId=688b3df66c3b82a56f1cfc97&type=detail
END
‘Staggering’ costs of e-scooter injuries are quantified for the first time for hospitals in Ireland
2025-09-28
ELSE PRESS RELEASES FROM THIS DATE:
People may age faster if their dad smoked during puberty
2025-09-28
People whose fathers smoked during puberty seem to age faster than expected, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1].
The researchers found signs of faster biological ageing, compared to chronological age, in people whose fathers began smoking at age 15 or younger. They say smoking during puberty may create damage in boys’ developing sperm cells that can be passed on to their children.
The researchers call for stronger efforts to prevent tobacco use in teenagers, not only ...
Higher levels of air pollution linked to worsening of sleep apnea
2025-09-28
People who have obstructive sleep apnoea (OSA) may suffer worse symptoms if they live in areas with higher levels of air pollution, according to a multi-national study presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1].
Patients with OSA often snore loudly, their breathing starts and stops during the night, and they may wake up several times. Not only does this cause excessive sleepiness, but it can also increase the risk of high blood pressure, stroke, heart disease and type 2 diabetes. OSA is very common, ...
ASTRO: New therapy delays progression of recurrent prostate cancer
2025-09-28
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease worsening compared with those who received SBRT alone, according to new clinical trial results from UCLA Health Jonsson Comprehensive Cancer Center researchers.
Findings from the trial, presented today at the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco, showed that men who received the radioligand drug ...
Low-dose radiation therapy offers substantial relief to people with painful knee osteoarthritis
2025-09-28
SAN FRANCISCO, September 28, 2025 — A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, placebo-controlled clinical trial.
The study showed patients with mild to moderate knee osteoarthritis reported significant reductions in pain and improved physical function in the four months after receiving the low dose of radiation, which was just a small fraction of what’s used to treat cancer. Because the study included a control group with simulated treatment, the researchers could distinguish ...
Radiopharmaceutical added to stereotactic radiation delays prostate cancer progression in patients with limited metastatic disease
2025-09-28
SAN FRANCISCO, September 28, 2025 — A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone.
The phase II LUNAR trial is the first randomized study to show that a treatment established for later-stage prostate cancer can delay progression and defer hormone therapy when added to high-precision radiation ...
First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer
2025-09-28
SAN FRANCISCO, September 28, 2025 — A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery — the first predictive biomarker in this setting.
In the first prospective, randomized trial to validate a predictive gene expression test for hormone therapy in prostate cancer, patients with a prostate tumor subtype known as luminal B had much lower risks of recurrence and metastasis when radiation was complemented by apalutamide, a type of hormone therapy. Patients without this tumor subtype, however, saw no improvement. ...
Specialised singing programmes can improve the symptoms and quality of life of people with lung disease
2025-09-28
Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomised-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1].
The study was presented by Professor Natasha Smallwood from Monash University, Melbourne, Australia.
Professor Smallwood told the Congress: “Chronic breathlessness is a common and highly distressing symptom for people with chronic obstructive pulmonary disease and interstitial lung disease. Yet there is a lack ...
Children with asthma who use at-home monitoring are half as likely to need hospital care
2025-09-28
Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, compared to those who only receive care from their medical team, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1]. Remote monitoring also helped keep children’s symptoms under control.
At-home monitoring involved children and their families using an app approximately once a month to answer questions ...
Combination inhaler reduces asthma attacks in children by almost half
2025-09-28
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated.
In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.
The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – ...
Low-cost drug shows promise for patients with life threating respiratory infections
2025-09-28
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London.
The study analysed data from almost 500 patients hospitalised with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those receiving standard care.
Heparin, a drug traditionally injected to treat blood clots, was tested in this study in an inhaled form, targeting the lungs directly. As well as acting as an anticoagulant, ...